These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 38945959)
41. Personalized Medicine: Genomics Trials in Oncology. Hayes DF; Schott AF Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667 [TBL] [Abstract][Full Text] [Related]
42. Applications of patient-derived tumor xenograft models and tumor organoids. Yoshida GJ J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904 [TBL] [Abstract][Full Text] [Related]
43. Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis. Le Compte M; Cardenas De La Hoz E; Peeters S; Smits E; Lardon F; Roeyen G; Vanlanduit S; Prenen H; Peeters M; Lin A; Deben C J Vis Exp; 2022 Dec; (190):. PubMed ID: 36622028 [TBL] [Abstract][Full Text] [Related]
44. ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies. Perréard M; Florent R; Divoux J; Grellard JM; Lequesne J; Briand M; Clarisse B; Rousseau N; Lebreton E; Dubois B; Harter V; Lasne-Cardon A; Drouet J; Johnson A; Le Page AL; Bazille C; Jeanne C; Figeac M; Goardon N; Vaur D; Micault E; Humbert M; Thariat J; Babin E; Poulain L; Weiswald LB; Bastit V BMC Cancer; 2023 Mar; 23(1):223. PubMed ID: 36894916 [TBL] [Abstract][Full Text] [Related]
45. Updates in Translational Science for Esophageal and Gastric Cancers. Hompe ED; Sachdeva UM Surg Oncol Clin N Am; 2024 Jul; 33(3):571-581. PubMed ID: 38789199 [TBL] [Abstract][Full Text] [Related]
46. Clinical translation of patient-derived tumour organoids- bottlenecks and strategies. Foo MA; You M; Chan SL; Sethi G; Bonney GK; Yong WP; Chow EK; Fong ELS; Wang L; Goh BC Biomark Res; 2022 Mar; 10(1):10. PubMed ID: 35272694 [TBL] [Abstract][Full Text] [Related]
47. Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review. Flood M; Narasimhan V; Wilson K; Lim WM; Ramsay R; Michael M; Heriot A Ann Surg Oncol; 2022 Jan; 29(1):47-59. PubMed ID: 34596795 [TBL] [Abstract][Full Text] [Related]
48. Emerging organoid models: leaping forward in cancer research. Fan H; Demirci U; Chen P J Hematol Oncol; 2019 Dec; 12(1):142. PubMed ID: 31884964 [TBL] [Abstract][Full Text] [Related]
49. Tumor organoids: From inception to future in cancer research. Yang L; Yang S; Li X; Li B; Li Y; Zhang X; Ma Y; Peng X; Jin H; Fan Q; Wei S; Liu J; Li H Cancer Lett; 2019 Jul; 454():120-133. PubMed ID: 30981763 [TBL] [Abstract][Full Text] [Related]
51. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions. Nadauld LD; Ford JM; Pritchard D; Brown T Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728 [TBL] [Abstract][Full Text] [Related]
52. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice. Arnall JR; Petro R; Patel JN; Kennedy L J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708 [TBL] [Abstract][Full Text] [Related]
53. Patient-Derived Organoids for Precision Cancer Immunotherapy. Grönholm M; Feodoroff M; Antignani G; Martins B; Hamdan F; Cerullo V Cancer Res; 2021 Jun; 81(12):3149-3155. PubMed ID: 33687948 [TBL] [Abstract][Full Text] [Related]
54. Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion. Darrigues E; Zhao EH; De Loose A; Lee MP; Borrelli MJ; Eoff RL; Galileo DS; Penthala NR; Crooks PA; Rodriguez A Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639060 [TBL] [Abstract][Full Text] [Related]
55. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Golebiewska A; Hau AC; Oudin A; Stieber D; Yabo YA; Baus V; Barthelemy V; Klein E; Bougnaud S; Keunen O; Wantz M; Michelucci A; Neirinckx V; Muller A; Kaoma T; Nazarov PV; Azuaje F; De Falco A; Flies B; Richart L; Poovathingal S; Arns T; Grzyb K; Mock A; Herold-Mende C; Steino A; Brown D; May P; Miletic H; Malta TM; Noushmehr H; Kwon YJ; Jahn W; Klink B; Tanner G; Stead LF; Mittelbronn M; Skupin A; Hertel F; Bjerkvig R; Niclou SP Acta Neuropathol; 2020 Dec; 140(6):919-949. PubMed ID: 33009951 [TBL] [Abstract][Full Text] [Related]
56. Progress in patient-derived liver cancer cell models: a step forward for precision medicine. Zhang Z; Hui L Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1707-1717. PubMed ID: 37766458 [TBL] [Abstract][Full Text] [Related]
57. Challenges, applications and future directions of precision medicine in prostate cancer - the role of organoids and patient-derived xenografts. Joshi A; Roberts MJ; Alinezhad S; Williams ED; Vela I BJU Int; 2020 Jul; 126(1):65-72. PubMed ID: 32383524 [TBL] [Abstract][Full Text] [Related]
58. Giving Up on Precision Oncology? Not So Fast! Warner JL Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309 [No Abstract] [Full Text] [Related]
59. Integration of Genomic Profiling and Organoid Development in Precision Oncology. Yoon H; Lee S Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642 [TBL] [Abstract][Full Text] [Related]